Trial Profile
Long-term immunogenicity and safety of inactivated Hantaan virus vaccine (Hantavax) in healthy adults.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Feb 2016
Price :
$35
*
At a glance
- Drugs Hantaan virus vaccine-(Hantavax) (Primary)
- Indications Hantaan virus infections
- Focus Adverse reactions; Therapeutic Use
- 03 Feb 2016 New trial record
- 27 Jan 2016 Results published in the Vaccine